Mason & Associates (California)’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Hold |
4,944
| – | – | 0.07% | 94 |
|
|
2025
Q1 | $298K | Sell |
4,944
-42,593
| -90% | -$2.56M | 0.07% | 90 |
|
|
2024
Q4 | $2.77M | Sell |
47,537
-556
| -1% | -$32.4K | 0.65% | 27 |
|
|
2024
Q3 | $2.85M | Sell |
48,093
-23,841
| -33% | -$1.41M | 0.71% | 23 |
|
|
2024
Q2 | $4.03M | Sell |
71,934
-604
| -0.8% | -$33.8K | 1.07% | 22 |
|
|
2024
Q1 | $4.25M | Buy |
72,538
+4,933
| +7% | +$289K | 1.13% | 20 |
|
|
2023
Q4 | $3.65M | Buy |
67,605
+352
| +0.5% | +$19K | 1.07% | 14 |
|
|
2023
Q3 | $3.26M | Buy |
67,253
+1,689
| +3% | +$81.9K | 1.04% | 17 |
|
|
2023
Q2 | $3.7M | Buy |
65,564
+1,817
| +3% | +$103K | 1.09% | 15 |
|
|
2023
Q1 | $3.44M | Sell |
63,747
-702
| -1% | -$37.9K | 1.05% | 15 |
|
|
2022
Q4 | $3.39M | Sell |
64,449
-1,425
| -2% | -$74.9K | 1.08% | 16 |
|
|
2022
Q3 | $3.11M | Buy |
65,874
+1,206
| +2% | +$56.9K | 1.1% | 18 |
|
|
2022
Q2 | $3.26M | Sell |
64,668
-74,550
| -54% | -$3.76M | 1.15% | 19 |
|
|
2022
Q1 | $8.49M | Buy |
139,218
+925
| +0.7% | +$56.4K | 2.59% | 13 |
|
|
2021
Q4 | $9.11M | Buy |
+138,293
| New | +$9.11M | 2.77% | 13 |
|